What is Vezeeta?
Founded in 2012 and headquartered in Cairo, Egypt, Vezeeta operates at the intersection of technology and healthcare. The company offers a comprehensive digital solution designed to streamline appointment scheduling and enhance practice management for healthcare providers. By digitizing the patient-doctor interaction and administrative processes, Vezeeta aims to improve efficiency and accessibility within the healthcare ecosystem. Its platform serves as a critical tool for clinics and individual practitioners seeking to modernize their operations and engage more effectively with patients.
How much funding has Vezeeta raised?
Vezeeta has raised a total of $17M across 2 funding rounds:
Series B
$5M
Series C
$12M
Series B (2016): $5M with participation from Vostok New Ventures and BECO Capital
Series C (2018): $12M, investors not publicly disclosed
Key Investors in Vezeeta
Vostok New Ventures
Vostok New Ventures, based in Stockholm, Sweden, is an investment firm focused on long-term profitability through patient capital and network effect businesses. They are opportunistic investors in business models that create strong competitive advantages.
BECO Capital
BECO Capital is an investment firm that likely focuses on technology and growth-stage companies, providing strategic backing to help businesses scale and achieve market leadership.
What's next for Vezeeta?
The recent infusion of capital signifies a pivotal moment for Vezeeta, positioning it for accelerated growth and market penetration. This strategic investment is expected to fuel further development of its technology, enhance its service offerings, and potentially expand its geographical reach. As Vezeeta continues to scale its operations, it is poised to solidify its position as a leader in the digital health sector, driving innovation in how healthcare services are accessed and managed.
See full Vezeeta company page
